Fred J. Dotzler

Fred J.
Dotzler founded De Novo Ventures LLC in 2000, where he is working as Managing Director from 2000 and Medicus Venture Partners in 1989, where he worked as Managing General Partner from 2009 to 2011.
Mr. Dotzler also currently works at Astute Medical, Inc., as Director, GenoRx, Inc., as Director, and Cartilix, Inc., as Director.
Mr. Dotzler also formerly worked at HemaQuest Pharmaceuticals, Inc., as Chairman, Bayhill Therapeutics, Inc., as Director from 2004 to 2013, SenoRx, Inc., as Director from 1998 to 2002, SenoRx, Inc., as Director from 2003 to 2010, iScience Interventional Corp., as Director, VitreoRetinal Technologies, Inc., as Director, Talima Therapeutics, Inc., as Director, Crosspoint Venture Partners, as General Partner, Merrimack Pharmaceuticals, Inc., as Principal, International Business Machines Corp., as Principal, G.D.
Searle & Co., Inc., as Principal, and EMD Millipore Corp., as Principal.
Mr. Dotzler received his graduate degree from Université Catholique de Louvain, undergraduate degree from Iowa State University, and Masters Business Admin degree from The University of Chicago.